Pfizer shifts Viagra consumer to McGarryBowen

Share this article:

Pfizer has given McCann HumanCare the heave-ho on its Viagra consumer account, awarding the business to Dentsu's McGarryBowen following a review.

A Pfizer spokesperson said a review continues and confirmed that McGarryBowen had been selected to handle DTC, but declined to specify what other elements of the brand's business are up for grabs.

The move, first reported by Advertising Age, follows Pfizer's shift of consumer advertising for Chantix from McCann HumanCare to McGarryBowen in January. The Interpublic Group agency still has some Pfizer consumer business, including assignments for Toviaz, Detrol and, through Pfizer's joint venture with Eisai, Aricept.

In addition, McCann's roster includes Wyeth Consumer Healthcare's Caltrate and Centrum. Pfizer and Wyeth announced plans to merge in January.

McCann HumanCare has handled the Viagra consumer business since 2004. The shop's last TV spot for the brand, dubbed "Reflection," broke Monday.


Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...